首页|期刊导航|生物医学研究杂志（英文版）|Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases

Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases

Colin T.Konishi Chengzu Long

生物医学研究杂志（英文版）2021，Vol.35Issue(2)：148-162,15.

Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases

Colin T.Konishi ¹Chengzu Long¹

作者信息

1. Leon H.Charney Division of Cardiology, New York University Grossman School of Medicine, New York, NY 10016, USA
折叠

摘要

关键词

gene editing/CRISPR-associated protein 9/CRISPR-Cas system/genetic disease/medical genetics/genetic therapy

Key words

gene editing/CRISPR-associated protein 9/CRISPR-Cas system/genetic disease/medical genetics/genetic therapy

分类

生物科学

引用本文复制引用

Colin T.Konishi,Chengzu Long..Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases[J].生物医学研究杂志（英文版）,2021,35(2):148-162,15.

基金项目

We thank Dr.Joseph Miano for constructive criticism of the manuscript.This work was supported by grants from DHPS Foundation and Kids Connect Charitable Fund. （）

生物医学研究杂志（英文版）

OACSCD

ISSN：1674-8301

访问量0

下载量0

段落导航